1999•Zhonghua miniao waike zazhiRequires access

Expression and Function of TNF α cDNA mutant in human bladder cancer EJ cell lines

Qin Dashan

Open publisher page 0 citations

Abstract

Objective To study the function of a gene mutant of tumor necrosis factor α (TNF α) in bladder cancer. Methods A TNF α cDNA mutant was selected as the target gene.The novel mutant was transduced into human bladder cancer EJ cell lines with the plasmid pcDNA 3.1(+) as the vector by the method of calcium phosphate DNA coprecipitation. Results Polymerase chain reaction (PCR) analysis confirmed the exogenic gene was stably integrated into EJ cell lines.The level of TNF α in the supernatant collected from EJ cells transfected with TNF α cDNA mutant was (0.664±0.225)ng/ml by radioimmunoassay (RIA) and L929 bioassay showed its cytotoxicity was 4~8U/ml.The formation ability of clony in soft agar was decreased significantly and the inhibition rate was 36.5%. Conclusions The TNF α cDNA mutant can be used in gene therapy for bladder cancer.

About this research paper

What this paper is about

Objective To study the function of a gene mutant of tumor necrosis factor α (TNF α) in bladder cancer. Methods A TNF α cDNA mutant was selected as the target gene.The novel mutant was transduced into human bladder cancer EJ cell lines with the plasmid pcDNA 3.1(+) as the vector by the method of calcium phosphate DNA coprecipitation. Results Polymerase chain reaction (PCR) analysis confirmed the exogenic gene was stably integrated into EJ cell lines.The level of TNF α in the supernatant collected from EJ cells transfected with TNF α cDNA mutant was (0.664±0.225)ng/ml by radioimmunoassay (RIA) and L929 bioassay showed its cytotoxicity was 4~8U/ml.The formation ability of clony in soft agar was decreased significantly and the inhibition rate was 36.5%. Conclusions The TNF α cDNA mutant can be used in gene therapy for bladder cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the function of a gene mutant of tumor necrosis factor α (TNF α) in bladder cancer. Methods A TNF α cDNA mutant was selected as the target gene.The novel mutant was transduced into human bladder cancer EJ cell lines with the plasmid pcDNA 3.1(+) as the vector by the method of calcium phosphate DNA coprecipitation. Results Polymerase chain reaction (PCR) analysis confirmed the exogenic gene was stably integrated into EJ cell lines.The level of TNF α in the supernatant collected from EJ cells transfected with TNF α cDNA mutant was (0.664±0.225)ng/ml by radioimmunoassay (RIA) and L929 bioassay showed its cytotoxicity was 4~8U/ml.The formation ability of clony in soft agar was decreased significantly and the inhibition rate was 36.5%. Conclusions The TNF α cDNA mutant can be used in gene therapy for bladder cancer.

Key concepts: Complementary DNA, Mutant, Molecular biology, Transfection, Cell culture, Gene, Tumor necrosis factor alpha, Plasmid

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and Function of TNF α cDNA mutant in human bladder cancer EJ cell lines — Research Paper | ScholarLens